CTT Pharmaceutical Holdings, Inc. is a development stage company. The Company specializes in drug delivery systems technology within the pharmaceutical industry. The Company’s focus is on fast dissolving drug delivery systems through the development of advanced oral delivery thin wafers. The Company's technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts, such as tetrahydrocannabinol (THC), cannabidiol (CBDs), terpenes to deliver treatment as an alternate to smoking and ingestion. The Company’s products include MedWAFE, CannaWAFE, and VetWAFE. MedWAFE reduces the opioid dosage and helps to reduce addiction and improve the patients' safety. CannaWAFE is a flavored wafer that provides users with a smoke-free alternative with proper dosage control. VetWAFE is a thin film for treating dogs and cats. The Company’s wholly owned subsidiary is CTT Pharmaceuticals Inc.